Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-03-15-Speech-4-035"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2001-03-15"^^xsd:date2
dcterms:Is Part Of	lp_eu:Biotechnology industry2
dcterms:Language	"nl"^^xsd:language2
lpv:document identification number	"en.20010315.4.4-035"2
lpv:hasSubsequent	lp_eu:2001-03-15-Speech-4-0362
lpv:speaker	lp:Elly Plooij-van Gorsel2
lpv:spokenAs	member; ELDR (1999-07-20--2004-07-19)3 member; Delegation for relations with the People's Republic of China (1999-09-29--2002-01-14)3 unknown; Volkspartij voor Vrijheid en Democratie (1999-07-20--2004-07-19)3 vice-chair; Temporary committee on the Echelon interception system (2000-07-11--2001-09-05)3 substitute; BUDG (1999-07-21--2002-01-14)3 member; Committee on Industry, External Trade, Research and Energy (1999-07-21--2002-01-14)3 substitute; Committee on Women's Rights and Equal Opportunities (1999-07-21--2002-01-14)3
lpv:translated text	"Mr President, ladies and gentlemen, Commissioner, I compliment Mr Purvis on his own-initiative report, which in terms of content does justice to the importance of the biotechnology sector for the European economy but which in the view of the ELDR Group could have been more balanced in its choice of words. For that reason we shall support Amendments Nos 1, 2, 25 and 27. Biotechnology, along with information and communications technology, is among the most promising technologies of the twenty-first century; in the years ahead these sectors will provide much new employment worldwide. A precondition for this will be that the European Union develops a transparent and innovation-promoting regulatory framework, as well as an encouraging entrepreneurial climate. Up to now, the biotechnology sector has been the lame duck as regards legislation facilitating economic support. Consequently, I welcome the Anglo-Dutch initiative to make biotechnology a key priority on the Stockholm agenda. If the European Union wishes to become the most dynamic and competitive knowledge economy, it is now time to create a alongside an . I am glad that the Dutch Prime Minister has realised this. Perhaps he can also persuade his party in the Netherlands parliament to withdraw its appeal to the European Court of Justice against the directive protecting biotechnological inventions. Because without sound patent legislation there will be no new investment by companies, no biotech start-ups and hence no innovation or employment. Finally, I hope that our Commissioner will inform Parliament speedily about the Stockholm summit and what has been decided there with regard to biotechnology. Perhaps he could suggest changing the acronym GMO to GEM, genetically enhanced materials, since ‘gems are precious stones’, and that is what biotechnology must become in Europe."@en1
lpv:unclassifiedMetadata	"‘B-Europe’"1 "‘E-Europe’"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph